NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
05/10/2019
Back to search
Official data from USPTO
EYEGENE NATIONAL OPHTHALMIC DISEASE GENOTYPING NETWORK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/10/2019
Trademark type
Combined
Nice classes
16, 42
Filing date
12/01/2008
Registration date
10/06/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/10/2019
Last transaction
05/10/2019
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
03/01/2007
First use in commerce
03/01/2007
Drawing code
3
Owner type
99
Owner location
Bethesda, MD
Examiner
MORENO, PAUL
Law office
L30
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of a design of an eye with a helix inside the pupil and the wording "NATIONAL OPHTHALMIC DISEASE GENOTYPING NETWORK" to the right above the wording "EYEGENE".
Holders and representatives
Holders
D. S. (pessoa física)
Representatives
HHS Office of the General Counsel
Technical classification
Nice Classes
Class 16Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed educational materials for physicianshealth care providerspatients in printed formatbrochures and postersfeaturing information on research and clinical trials to study the genetic causes of ocular diseases
Class 42
Research on the subject of the genetic causes of ocular diseases; providing websites featuring information on a national ophthalmic disease genotyping networka repository of genetic informationclinical trials to study the genetic causes of ocular diseases
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/10/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/10/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/05/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
04/05/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/06/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/09/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/09/2014
E815
TEAS SECTION 8 & 15 RECEIVED
11/17/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
10/06/2009
DOCK
ASSIGNED TO EXAMINER
07/22/2009
PUBO
PUBLISHED FOR OPPOSITION
07/21/2009
NPUB
NOTICE OF PUBLICATION
07/01/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/15/2009
ALIE
ASSIGNED TO LIE
06/15/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/11/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/07/2009
GNRT
NON-FINAL ACTION E-MAILED
03/07/2009
CNRT
NON-FINAL ACTION WRITTEN
03/07/2009
DOCK
ASSIGNED TO EXAMINER
02/27/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/18/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/18/2009
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
12/05/2008
NWAP
NEW APPLICATION ENTERED
12/04/2008
Continuous trademark protection
Get notified about every new filing that threatens EYEGENE NATIONAL OPHTHALMIC DISEASE GENOTYPING NETWORK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.